2 results
Approved WMOCompleted
The primary objectives of the Phase Ib portion of the study are as follows:* To assess the safety and tolerability of the combination of polatuzumab vedotin with bendamustine and rituximab (BR) or bendamustine and obinutuzumab (BG) when administered…
Not approvedWill not start
The main goal of this study is to determine whether the CGM can replace venipunctures to measure blood glucose values during the oGTT.The second goal of this study is to investigate to what extent glucose profiles, measured at home using the CGM,…